申请人:Cerus Corporation
公开号:US20030082510A1
公开(公告)日:2003-05-01
Psoralen compound compositions are synthesized which have primaryamino substitutions on the 3-, 4-, 5-, and 8-positions of the psoralen, which yet permit their binding to nucleic acid of pathogens. Reaction conditions that photoactivate these psoralens result in the inactivation of pathogens which contain nucleic acid. The compounds show similar activity in test systems to 4′ and 5′ derivatives of psoralen useful for inactivation of pathogens in blood products. In addition to the psoralen compositions, the invention contemplates such inactivating methods using the new psoralens.
合成了一种含有3-、4-、5-和8-位置的主要氨基取代基的芳香光毒素化合物组合物,但仍允许它们与病原体的核酸结合。光活化这些芳香光毒素的反应条件导致含有核酸的病原体失活。这些化合物在测试系统中显示出与用于血液制品中病原体失活的4'和5'衍生物的类似活性。除了芳香光毒素组合物外,本发明还考虑使用新的芳香光毒素进行失活方法。